Pasar al contenido principal

LIPOUNIVERSAL,PLATAFORMA PARA EL DIAGNOSTICO UNIVERSAL DE LA HIPERCOLESTEROLEMIA FAMILIAR

IPT-2011-0817-010000

•
Nombre agencia financiadora Ministerio de Ciencia e Innovación
Acrónimo agencia financiadora MICINN
Programa Programa Nacional de Cooperación Público-Privada
Subprograma Subprograma INNPACTO
Convocatoria INNPACTO
Año convocatoria 2011
Plan Estatal 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Unidad de gestión Subdirección General de Estrategias de Colaboracion Publico-Privada
Centro beneficiario PROGENIKA BIOPHARMA, S.A.
Identificador persistente http://dx.doi.org/10.13039/501100004837

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The p.Leu167del Mutation in APOE Gene Causes Autosomal Dominant Hypercholesterolemia by Down-regulation of LDL Receptor Expression in Hepatocytes

  • Cenarro, Ana
  • Etxebarria, Aitor
  • Castro-Orós, Isabel de
  • Stef, Marianne
  • Bea, Ana M
  • Palacios, Lourdes
  • Mateo-Gallego, Rocío
  • Benito-Vicente, Asier
  • Ostolaza, Helena
  • Tejedor, Teresa
  • Martín, César
  • Civeira, Fernando
[Context] The p.Leu167del mutation in the APOE gene has been associated with hyperlipidemia., [Objectives] Our objective was to determine the frequency of p.Leu167del mutation in APOE gene in subjects with autosomal dominant hypercholesterolemia (ADH) in whom LDLR, APOB, and PCSK9 mutations had been excluded and to identify the mechanisms by which this mutant apo E causes hypercholesterolemia., [Design] The APOE gene was analyzed in a case-control study., [Setting] The study was conducted at a University Hospital Lipid Clinic., [Patients or Other Participants] Two groups (ADH, 288 patients; control, 220 normolipidemic subjects) were included., [Intervention] We performed sequencing of APOE gene and proteomic and cellular experiments., [Main Outcome Measure] To determine the frequency of the p.Leu167del mutation and the mechanism by which it causes hypercholesterolemia., [Results] In the ADH group, nine subjects (3.1%) were carriers of the APOE c.500_502delTCC, p.Leu167del mutation, cosegregating with hypercholesterolemia in studied families. Proteomic quantification of wild-type and mutant apo E in very low-density lipoprotein (VLDL) from carrier subjects revealed that apo E3 is almost a 5-fold increase compared to mutant apo E. Cultured cell studies revealed that VLDL from mutation carriers had a significantly higher uptake by HepG2 and THP-1 cells compared to VLDL from subjects with E3/E3 or E2/E2 genotypes. Transcriptional down-regulation of LDLR was also confirmed., [Conclusions] p.Leu167del mutation in APOE gene is the cause of hypercholesterolemia in the 3.1% of our ADH subjects without LDLR, APOB, and PCSK9 mutations. The mechanism by which this mutation is associated to ADH is that VLDL carrying the mutant apo E produces LDLR down-regulation, thereby raising plasma low-density lipoprotein cholesterol levels., This work was supported by grants from the Spanish Ministry of Health (FIS PI13/02507, FIS PI12/01087, RETIC RD12/0042/0055 (RIC)) and the Spanish Ministry of Economy and Competitiveness (INNPACTO IPT-2011–0817)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Activity-associated effect of LDL receptor missense variants located in the cysteine-rich repeats

  • Etxebarria, Aitor
  • Benito-Vicente, Asier
  • Stef, Marianne
  • Ostolaza, Helena
  • Palacios, Lourdes
  • Martín, César
[Background] The LDL receptor (LDLR) is a Class I transmembrane protein critical for the clearance of cholesterol-containing lipoprotein particles. The N-terminal domain of the LDLR harbours the ligand-binding domain consisting of seven cysteine-rich repeats of approximately 40 amino acids each. Mutations in the LDLR binding domain may result in loss of receptor activity leading to familial hypercholesterolemia (FH). In this study the activity of six mutations located in the cysteine-rich repeats of the LDLR has been investigated., [Methods] CHO-ldlA7 transfected cells with six different LDLR mutations have been used to analyse in vitro LDLR expression, lipoprotein binding and uptake. Immunoblotting of cell extracts, flow cytometry and confocal microscopy have been performed to determine the effects of these mutations. In silico analysis was also performed to predict the mutation effect., [Results and conclusion] From the six mutations, p.Arg257Trp turned out to be a non-pathogenic LDLR variant whereas p.Cys116Arg, p.Asp168Asn, p.Asp172Asn, p.Arg300Gly and p.Asp301Gly were classified as binding-defective LDLR variants whose effect is not as severe as null allele mutations., This work was supported by the Spanish Ministry of Economy and Competitiveness, Programa INNPACTO (grant N° IPT-2011-0817-010000) and from the Spanish Ministerio de Ciencia y Tecnología (Project BFU 2012–36241), and the Basque Government (Grupos Consolidados IT849-13 and ETORTEK Program)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Functional Characterization and Classification of Frequent Low-Density Lipoprotein Receptor Variants

  • Etxebarria, Aitor
  • Benito-Vicente, Asier
  • Palacios, Lourdes
  • Stef, Marianne
  • Cenarro, Ana
  • Civeira, Fernando
  • Ostolaza, Helena
  • Martín, César
Familial hypercholesterolemia (FH) is an autosomal-dominant disorder mostly caused by mutations in the low-density lipoprotein receptor (LDLR) gene leading to increased risk for premature cardiovascular diseases. According to functional studies, LDLR mutations may be classified into five classes. The main objective of this study was to characterize seven LDLR variants previously detected in FH patients. Analysis by flow cytometry and confocal microscopy of LDLR activity demonstrate that all the studied variants are pathogenic. Among the mutations located in β-propeller, p.Trp577Gly and p.Ile624del were classified as class 2, whereas p.Arg416Trp and p.Thr454Asn as class 5. p.Phe800Glyfs*129 (located in the cytoplasmic domain), p.Cys155Tyr (located in the binding domain), and p.Asn825Lys (inside FxNPxY motif) were classified as class 2, 3, and 4, respectively. The results also show that LDLR activity of these class 4 and 5 variants is not completely abolished, showing a milder phenotype. We have also determined that statin response is more efficient lowering total cholesterol in heterozygous patients carrying p.Ile624del (class 2) compared with p.Arg416Trp and p.Thr454Asn (class 5) variants. In conclusion, these findings emphasize the importance of characterizing LDLR pathogenic variants to provide an indisputable FH diagnosis and to gain insight into the statin response depending on the LDLR class mutation., Contract grant sponsors: Spanish Ministry of Economy and Competitiveness, Programa INNPACTO (grant No IPT-2011-0817-010000), Spanish Ministerio de Ciencia y Tecnología (Project BFU 2012-36241), and FIS PI12/01087)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The importance of an integrated analysis of clinical, molecular, and functional data for the genetic diagnosis of familial hypercholesterolemia

  • Benito-Vicente, Asier
  • Alves, Ana Catarina
  • Etxebarria, Aitor
  • Medeiros, Ana Margarida
  • Martín, César
  • Bourbon, Mafalda
[Purpose] Familial hypercholesterolemia (FH) is one of the most common monogenic disorders, and the high concentrations of low-density lipoprotein (LDL) cholesterol presented since birth confers on these patients an increased cardiovascular risk. More than 1,600 alterations have been described in the LDL receptor gene (LDLR), but a large number need to be validated as mutations causing disease to establish a diagnosis of FH. This study aims to characterize, both at the phenotypic and genotypic levels, families with a clinical diagnosis of FH and present evidence for the importance of the integration of clinical, molecular, and functional data for the correct diagnosis of patients with FH., [Methods] A detailed analysis of the phenotype and genotype presented by 55 families with 13 different alterations in the LDLR was conducted. For eight of these, an extensive functional characterization was performed by flow cytometry, confocal microscopy, and reverse transcriptase polymerase chain reaction., [Results] Carriers of neutral alterations presented a significantly lower incidence of premature cardiovascular disease, lower levels of atherogenic lipoproteins and a large number of these individuals had LDL-cholesterol values below the 75th percentile. presented a significantly lower incidence of premature cardiovascular disease, lower levels of atherogenic lipoproteins and a large number of these individuals had LDL-cholesterol values below the 75th percentile However, the functional study was essential to determine the pathogenicity of variants., [Conclusion] The data collected illustrate the importance of this integrated analysis for the correct assessment of patients with FH who can otherwise be misdiagnosed., Funding was obtained from the Portuguese Science and Technology Foundation (PTDC/SAU-GMG/101874/2008), the Spanish Ministry of Economy and Competitiveness (grant BFU 2012–36241), and Programa INNPACTO (grant IPT-2011-0817-010000). A.C.A. was supported by a PhD student grant (SFRH/BD/27990/2006) and a research grant from PTDC/SAU-GMG/101874/2008., Peer reviewed